Gene study links ZIP8 to alcohol cravings
NCT ID NCT06819189
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 3 times
Summary
This study looks at how a gene called ZIP8 influences alcohol drinking and its effects on the brain. Healthy volunteers aged 21 to 60 of European ancestry will receive alcohol through an IV and can choose how much to take. Brain scans and questionnaires will help researchers understand the link between genetics and alcohol-related behaviors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ethanol (alcohol given intravenously)
- What this could lead to
- If successful, this could help explain why some people are more prone to alcohol use disorder, potentially guiding future prevention or treatment strategies.
- What could go wrong
- This is an early-phase study in healthy volunteers, not a treatment trial. It may not reveal clear genetic links, and results may not apply to people with alcohol use disorder or non-European ancestries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?